Given that cancer mortality is usually a result of late diagnosis, efforts in the field of early
detection are paramount to reducing cancer-related deaths and improving patient outcomes …

Simple Summary Early diagnosis of breast cancer greatly increases the chance of cure and
survival from the disease. The mammogram is widely used for early detection of breast …

MicroRNAs (miRNAs) are gene regulators involved in the pathogenesis of complex
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …

Luteolin is a flavonoid widely present in various traditional Chinese medicines. In recent
years, luteolin has received more attention due to its impressive liver protective effect, such …

Improved treatment of breast cancer, the world's second most common cancer, requires
identification of new sensitive prognostic and diagnostic biomarkers. Exosomes are lipid …

Breast cancer is the most prevalent non-cutaneous malignancy in women, with greater than
a million new cases every year. In the last decennium, numerous diagnostic and treatment …

The last two decades of cancer research have been devoted in two directions:(1)
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …

Over the last decades, microRNAs (miRNAs) have emerged as important molecules
associated with the regulation of gene expression in humans and other organisms …

Simple Summary In breast cancer development, the expression of Ki-67 is strongly
associated with cancer proliferation and is a known indicator of prognosis and outcome. Ki …

Sensitive imaging of microRNAs (miRNAs) in living cells is significant for accurate cancer
clinical diagnosis and prognosis research studies, but it is challenged by inefficient …